SI-BONE, Inc. (SIBN)

USD 13.54

(-2.17%)

Market Cap (In USD)

567.84 Million

Revenue (In USD)

138.88 Million

Net Income (In USD)

-43.33 Million

Avg. Volume

340.16 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11.7-21.7
PE
-
EPS
-
Beta Value
1.226
ISIN
US8257041090
CUSIP
825704109
CIK
1459839
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Ms. Laura A. Francis MBA
Employee Count
-
Website
https://si-bone.com
Ipo Date
2018-10-17
Details
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.